Trice Medical received CE Mark Approval and Health Canada approval for the mi-eye 2™ direct visualization tool, and announced completion of first cases in the regions.
mi-eye 2 received FDA 510(k) clearance in late 2016 and launched in the U.S. in 2017, where it’s now used in >200 settings. The technology is a handheld, single-use tool comprising a wide-angle camera lens embedded in a disposable needle. Physicians can complete a diagnosis on the spot in a clinic, under local anesthetic.
Trice Medical received CE Mark Approval and Health Canada approval for the mi-eye 2™ direct visualization tool, and announced completion of first cases in the regions.
mi-eye 2 received FDA 510(k) clearance in late 2016 and launched in the U.S. in 2017, where it's now used in >200 settings. The technology is a handheld, single-use tool...
Trice Medical received CE Mark Approval and Health Canada approval for the mi-eye 2™ direct visualization tool, and announced completion of first cases in the regions.
mi-eye 2 received FDA 510(k) clearance in late 2016 and launched in the U.S. in 2017, where it’s now used in >200 settings. The technology is a handheld, single-use tool comprising a wide-angle camera lens embedded in a disposable needle. Physicians can complete a diagnosis on the spot in a clinic, under local anesthetic.
Copy to clipboard 
